Whistleblower Showdown: Supreme Court Declines Eli Lilly's Appeal

The U.S. Supreme Court on Monday refused to consider drugmaker Eli Lilly's challenge against a longstanding whistleblower law. This Civil War-era act has enabled tens of billions in fraud recoveries for the U.S. by empowering private citizens to file lawsuits on behalf of the federal government.

Lilly was appealing a lower court ruling that imposed a $183 million judgment. This arose from a whistleblower suit alleging the company underpaid drug rebates to Medicaid. The suit was filed in 2014 by Ronald Streck under the False Claims Act, legislation designed to combat fraud against the government.

Originating during Abraham Lincoln's presidency, the act was a response to fraudulent supplier claims during the Civil War. A recent jury found Lilly guilty of misleading Medicaid, culminating in significant financial penalties. The Supreme Court's refusal to hear the appeal cements the False Claims Act's authority, despite the constitutional challenges raised by Lilly.

(With inputs from agencies.)